AccessMatters Applauds FDA Decision to Update Protocol for Medication Abortion
PHILADELPHIA, PA (April 1, 2016): Earlier this week, the U.S. Food and Drug Administration announced new guidelines for prescribing Mifepristone, a drug used for medication abortion. Melissa Weiler Gerber, President and CEO of AccessMatters released the following...
RT @JeffInnovation: “There are a lot of people out there who are trying to make you feel insecure about your body. The body you get is… https://t.co/QyaC8XyUmQ
Bd Chair Tiffany: For 45 years, AccessMatters has brought light to issues people don’t want to talk about & has car… https://t.co/cN5QrNQZGh
RT @AAKESQ: We have to understand and give respect to teens who are seeking healthcare. This may be the first time they’re seek… https://t.co/rw5n6dxrai
Al: If we want kids to speak up, we have to speak up @AlVsexed #AccessMatters45th https://t.co/NibCpzMXDh
Al: We fail teens as adults when we cannot initiate conversation with them in ways that are comfortable so one barr… https://t.co/1PayulUHwb